The guideline was drafted by a writing group identified by the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (BCSH). All the authors are consultants in haematology in the UK. A search was performed of PubMed and Embase using the term 'cancer' combined with 't...
Reyes-GarcÃa, R;
GarcÃa-MartÃn, A;
Varsavsky, M;
Rozas-Moreno, P;
Cortés-Berdonces, M;
Luque-Fernández, I;
Gómez Sáez, J. M;
Vidal Casariego, A;
Romero Muñoz, M;
Guadalix Iglesias, S;
Fernández GarcÃa, D;
Jódar Gimeno, E;
Muñoz Torres, M.
Objetivo: Actualizar las recomendaciones previas formuladas por el Grupo de trabajo de osteoporosis y metabolismo mineral de la Sociedad Española de EndocrinologÃa y Nutrición (SEEN) para la evaluación y el tratamiento de la osteoporosis asociada a diferentes enfermedades endocrinas y alteraciones nu...
Al-Hameed, F;
Al-Dorzi, H. M;
AlMomen, A;
Algahtani, F;
AlZahrani, H;
AlSaleh, K;
AlSheef, M;
Owaidah, T;
Alhazzani, W;
Neumann, I;
Wiercioch, W;
Brozek, J;
Schünemann, H;
Akl, E. A.
BACKGROUND AND OBJECTIVES: Venous thromboembolism (VTE) is commonly encountered in the daily clinical practice. Cancer is an important VTE risk factor. Proper thromboprophylaxis is key to prevent VTE in patients with cancer, and proper treatment is essential to reduce VTE complications and adverse events...
OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
El objetivo principal de la guÃa es proporcionar a los profesionales sanitarios, recomendaciones para la prevención, el diagnóstico y el manejo terapéutico de los pacientes con Linfoma B Difuso de célula grande (LBDCG), que presentan (o tienen riesgo de) afectación leptomenÃngea o del parénquima ...
Lymphome B diffus à grandes cellules/traitement médicamenteux,
Lymphome B diffus à grandes cellules/diagnostic,
Maladies du système nerveux central/étiologie,
Ponction lombaire/méthodes,
Biopsie/méthodes,
Spectroscopie par résonance magnétique/méthodes,
Méthotrexate/usage thérapeutique,
Rituximab/usage thérapeutique,
Antinéoplasiques/usage thérapeutique,
Approche GRADE,
Maladies du système nerveux central/prévention et contrôle
Hépatite C,
Antiviraux/usage thérapeutique,
Hépatite C/diagnostic,
Transplantation hépatique,
Contre-indications,
Surveillance des médicaments,
Association de médicaments,
Interférons/usage thérapeutique,
Maladie aigüe,
Hépatite C/étiologie,
Hépatite C/thérapie,
Hépatite C chronique/diagnostic,
Hépatite C chronique/étiologie,
Hépatite C chronique/thérapie
Górriz, J. L;
Gutiérrez, F;
Trullas, J. C;
Arazo, P;
Arribas, J. R;
Barril, G;
Cervero, M;
Cofan, F;
Domingo, P;
Estrada, V;
Fulladosa, X;
Galindo, M. J;
Gracia, S;
Iribarren, J. A;
Knobel, H;
López-Aldeguer, J;
Lozano, F;
MartÃnez-Castelao, A;
MartÃnez, E;
Mazuecos, M. A;
Miralles, C;
Montañés, R;
Negredo, E;
Palacios, R;
Pérez-ElÃas, M. J;
Portilla, J;
Praga, M;
Quereda, C;
Rivero, A;
SantamarÃa, J. M;
Sanz, J;
Miró, J. M.
OBJETIVO: Actualizar las recomendaciones sobre la evaluación y el manejo de la afectación renal en pacientes con infección por el virus de la inmunodeficiencia humana (VIH). MÉTODOS: Este documento ha sido consensuado por un panel de expertos del Grupo de Estudio de Sida (GESIDA) de la Sociedad EspaÃ...
Disminuir la heterogeneidad de la atención pre e intrahospitalaria del TCE severo en Colombia para generar una práctica basada en evidencia cientÃfica. Establecer criterios para la referencia yel traslado de pacientes adultos con TCE dentro de un sistema de atención en trauma. Promover una eficienci...
Kantor, PF;
Lougheed, J;
Dancea, A;
McGillion, M;
Barbosa, N;
Chan, C;
Dillenburg, R;
Atallah, J;
Buchholz, H;
Chant-Gambacort, C;
Conway, J;
Gardin, L;
George, K;
Greenway, S;
Human, DG;
Jeewa, A;
Price, JF;
Ross, RD;
Roche, SL;
Ryerson, L;
Soni, R;
Wilson, J;
Wong, K.
Pediatric heart failure (HF) is an important cause of morbidity and mortality in childhood. This article presents guidelines for the recognition, diagnosis, and early medical management of HF in infancy, childhood, and adolescence. The guidelines are intended to assist practitioners in office-based or em...
Antagonistes du récepteur de type 1 de l'angiotensine-II/usage thérapeutique,
Inhibiteurs de l'enzyme de conversion de l'angiotensine,
Marqueurs biologiques/sang,
Cardiotoniques,
Catécholamines/usage thérapeutique,
Diurétiques,
Vasodilatateurs,
Vasopressines,
Cardiopathies congénitales,
Mort subite cardiaque/étiologie,
Défaillance cardiaque,
Myocardite,
Échocardiographie,
Électrocardiographie ambulatoire,
Algorithmes,
Cardiopathies congénitales/diagnostic,
Cardiopathies congénitales/thérapie,
Myocarde/anatomopathologie,
Mort subite cardiaque/prévention et contrôle
These WHO mhGAP guidelines were developed to provide recommended management strategies for conditions specifically related to stress, including symptoms of acute stress, post-traumatic stress disorder and bereavement. The guidelines were developed by an independent Guidelines Development Group and inform...
Troubles de stress traumatique aigus/complications,
Troubles de stress traumatique aigus/psychologie,
Troubles de stress traumatique aigus/thérapie,
Troubles de l'endormissement et du maintien du sommeil/étiologie,
Énurésie/étiologie,
Hyperventilation/étiologie,
Troubles dissociatifs/étiologie,
Troubles de l'endormissement et du maintien du sommeil/thérapie,
Énurésie/thérapie,
Hyperventilation/thérapie,
Troubles dissociatifs/thérapie
